Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Scientific Reports|May 6, 2020
The limitations of targeting MEK signalling in Glioblastoma therapyKarthika D Selvasaravanan, Nicole Wiederspohn, Amina Hadzalic, et al.Plos One|June 30, 2015
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma TherapyStephanie Ströbele, Matthias Schneider, Lukas Schneele, et al.Expert Opinion on Drug Discovery|August 23, 2022
Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressureSophia Konig, Hannah Strobel, Michael Grunert, et al.Journal of Neuro-Oncology|December 20, 2014
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effectGeorg Karpel-Massler, Richard Eric Kast, Mike-Andrew Westhoff, et al.Blood|December 5, 2018
<i>FBXW7</i> mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.Oncotarget|November 3, 2016
Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cellsMadleen Giese, Nadine Turiello, Nicole Molenda, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2013
Antiviral vaccines license T cell responses by suppressing granzyme B levels in human plasmacytoid dendritic cellsDorit Fabricius, Benedikt Nußbaum, Daniel Busch, et al.Critical Reviews in Oncogenesis|June 29, 2018
Radiation and Brain Tumors: An OverviewMichael Grunert, Rebecca Kassubek, Burkhardt Danz, et al.British Journal of Cancer|March 3, 2020
Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastomaMaximilian Pruss, Annika Dwucet, Mine Tanriover, et al.Biomedicines|June 10, 2020
Considering the Experimental use of Temozolomide in Glioblastoma ResearchVerena J Herbener, Timo Burster, Alicia Goreth, et al.Pageof 9